The rearrangement of BCL2, BCL6, or PAX5 alone has not been associated with worse outcome in DLBCL patients 26, 27, while the prognostic impact of CCND1 rearrangement in DLBCL has been controversial 28. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.